Thus, IL-17 treatment had enhanced the frequency of dividing cells among the GSC (CD133+IL-17R+) population in both primary glioma and U87-MG cultures, suggesting that IL-17 potentially enhances proliferation or self-renewal of GSCs. The gene discussed is IL17A; the disease is central nervous system cancer.